Skip to main content
All news

UF Innovation Enhances Cavity Risk Testing

Kyle Kasparian, a candidate in the UF College of Dentistry’s combined D.M.D./ Ph.D. program.

Kyle Kasparian, a candidate in the UF College of Dentistry’s combined D.M.D./ Ph.D. program.

When the Food and Drug Administration issued a safety warning in 2022 about severe tooth decay associated with a commonly prescribed orally dissolving opioid use disorder medication called buprenorphine, University of Florida researchers asked an important question: How could scientists better measure the oral conditions that put teeth at risk?

For Kyle Kasparian, a candidate in the UF College of Dentistry’s combined D.M.D./ Ph.D. program, answering that question became part of a broader research effort. His doctoral investigations seek to uncover the biological mechanism driving cavities associated with orally dissolving sublingual buprenorphine and, ultimately, to formulate a version of the drug that retains its important therapeutic benefits while reducing risks to patients' oral health.

“It will still be used to treat opioid use disorder,” Kasparian said. “However, we are designing the formulation so that it won’t have these associated cavity risks ... with more than 15 million prescriptions written for this medication each year, that will be a huge benefit.”

In the process, Kasparian and his collaborators encountered another problem, with implications well beyond a single medication. Researchers needed a better way to interpret oral pH data when measurements are only collected periodically.

Experts in dentistry, pharmaceutics, quantitative modeling and computer science rose to the challenge. Their efforts culminated in the invention of GatorpH: A free, online research tool designed to help scientists analyze dynamic changes in oral pH and estimate factors associated with cavity risk.

A mathematical blind spot

Tooth decay begins within dental plaque, a sticky biofilm that traps bacterial acids against tooth enamel. Because plaque limits saliva’s ability to neutralize those acids, acidity can remain at harmful levels long after the rest of the mouth returns to normal, leading to tooth mineral loss.

Federal regulations define a dietary item or sugar substitute as cavity-causing if it drops plaque pH below 5.7, the critical threshold at which tooth enamel begins to dissolve when bacteria ferment sugars during or up to 30 minutes after consumption.

Accurately capturing what happens to pH over time, however, presents researchers with a practical challenge. Continuous plaque-pH monitoring can provide detailed information about the rise and fall of acid levels, but the methodology is demanding.

Reliant on a wire telemetry device, the continuous monitoring approach requires patients to wear custom sensor-equipped mouthpieces while allowing plaque to accumulate — undisturbed by brushing — for multiple days. Historically, this made studies expensive, time-consuming and notoriously difficult to scale.

“Few studies have implemented this since the 2000s,” Kasparian said.

The alternative approach, and the method Kasparian set out to refine, is “sparse” pH sampling: taking occasional test-strip or probe readings every few minutes.

He found that medications or foods evaluated via sparse pH sampling could easily appear benign on paper while wreaking true tooth decay in real-world use.

Determining whether buprenorphine’s original pH testing had fallen into this mathematical trap became a central focus of Kasparian’s research.

Pharmacy and dentistry combine forces

As Kasparian launched a pilot cross-sectional study investigating oral pH changes among patients taking sublingual buprenorphine, the limitations of traditional modeling became increasingly apparent.

“That’s how the whole story of GatorpH started,” said one of Kasparian’s faculty mentors, Abhisheak Sharma, Ph.D., M.Pharm., associate chair of the UF College of Pharmacy’s Department of Pharmaceutics and co-director for the Translational Drug Development Core at UF.

The breakthrough occurred in a synchronistic collision of expertise. During a meeting among members of Sharma’s lab, Kasparian broached the subject of calculation inefficiencies in his study with Omar Elashkar, a College of Pharmacy graduate student with a background in quantitative modeling and computer science.

“They complemented each other,” Sharma said. “None of them could have done this alone.”

The model accounts for biological factors such as bacterial acid production and saliva buffering, eliminating the guesswork of traditional calculations. This advance allows researchers like Kasparian to accurately reconstruct acid changes with greater ease.

A free public oral health tool

That’s how GatorpH, an open-source software tool, came to fruition.

GatorpH reconstructs the curved trajectory of oral pH changes rather than relying on straight-line estimates between measurements. That means it can more accurately predict key cavity-causing risk factors.

“This software will not just solve Kyle’s problem with analyzing this clinical study data; it will also solve the problem for anybody doing this kind of study around the world,” Sharma said.

Others involved in the study include Christopher McCurdy, Ph.D., FAAPS, a distinguished professor of medicinal chemistry in the UF College of Pharmacy and director of the UF Translational Drug Development Core; Jacqueline Abranches, Ph.D., an associate professor in UFCD’s Department of Oral Biology; and John Abernethy, M.D., a courtesy faculty member in the UF College of Medicine and CEO of a Gainesville-based biopharmaceutical startup.

Abernethy brought the original clinical problem to the team’s attention and connected the researchers with community addiction physicians.

The team is now poised to use GatorpH for their ultimate objective: reformulating a version of buprenorphine that won’t cause cavities. To support the work, they have applied for National Institutes of Health funding.

The team’s decision to make the tool free to everyone for noncommercial use was an easy one, Sharma said.

“If something was developed using taxpayers’ money, it should be available to taxpayers,” he said. “Dental problems are the most prevalent problems around the globe. And if we can quantify that problem in terms of mathematics, if they can improve their life with one of our software tools, that’s the best way we could achieve impact in a public university.”

About the author

For the media

Media contact

Peyton Wesner
Communications Manager for UF Health External Communications
pwesner@ufl.edu (352) 273-9620